Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001209191-22-000861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2021-12-31 | YARW | Zeronda Tyler | Interim CFO | F - Tax | $1.02 | -206 | 87.3K | -0.2% | -$210.12 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | F | D | 206 | $1.02 | 87,329 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |